Influence of Water on Amorphous Lidocaine

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Influence of Water on Amorphous Lidocaine. / Xu, Xiaoyue; Grohganz, Holger; Rades, Thomas.

In: Molecular Pharmaceutics, Vol. 19, No. 9, 2022, p. 3199–3205.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Xu, X, Grohganz, H & Rades, T 2022, 'Influence of Water on Amorphous Lidocaine', Molecular Pharmaceutics, vol. 19, no. 9, pp. 3199–3205. https://doi.org/10.1021/acs.molpharmaceut.2c00339

APA

Xu, X., Grohganz, H., & Rades, T. (2022). Influence of Water on Amorphous Lidocaine. Molecular Pharmaceutics, 19(9), 3199–3205. https://doi.org/10.1021/acs.molpharmaceut.2c00339

Vancouver

Xu X, Grohganz H, Rades T. Influence of Water on Amorphous Lidocaine. Molecular Pharmaceutics. 2022;19(9):3199–3205. https://doi.org/10.1021/acs.molpharmaceut.2c00339

Author

Xu, Xiaoyue ; Grohganz, Holger ; Rades, Thomas. / Influence of Water on Amorphous Lidocaine. In: Molecular Pharmaceutics. 2022 ; Vol. 19, No. 9. pp. 3199–3205.

Bibtex

@article{7256d1f540bf4b3d814a95be08fff281,
title = "Influence of Water on Amorphous Lidocaine",
abstract = "Water is generally regarded as a universal plasticizer of amorphous drugs or amorphous drug-containing systems. A decrease in glass-transition temperature (T-g) is considered the general result of this plasticizing effect. A recent study exhibits that water can increase the T-g of amorphous prilocaine (PRL) and thus shows an anti-plasticizing effect. The structurally similar drug lidocaine (LID) might show similar interactions with water, and thus an anti-plasticizing effect of water is hypothesized to also occur in amorphous LID. However, the influence of water on the T-g of LID cannot be determined directly due to the very low stability of LID in the amorphous form. It is possible to predict the T-g of LID from a co-amorphous system of PRL-LID using the Gordon-Taylor equation. Interactions were observed between PRL and LID based on the deviations between the experimental T(g)s and the T(g)s calculated by the conventional use of the Gordon-Taylor equation. A modified use of the Gordon-Taylor equation was applied using the optimal co-amorphous system as a separate component and the excess drug as the other component. The predicted T-g of fully hydrated LID could thus be determined and was found to be increased by 0.9 +/- 0.7 K compared with the T-g of water-free amorphous LID. It could be shown that water exhibited a small anti-plasticizing effect on LID.",
keywords = "co-amorphous, glass transition, molecular interaction, anti-plasticizing effect, lidocaine",
author = "Xiaoyue Xu and Holger Grohganz and Thomas Rades",
year = "2022",
doi = "10.1021/acs.molpharmaceut.2c00339",
language = "English",
volume = "19",
pages = "3199–3205",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "9",

}

RIS

TY - JOUR

T1 - Influence of Water on Amorphous Lidocaine

AU - Xu, Xiaoyue

AU - Grohganz, Holger

AU - Rades, Thomas

PY - 2022

Y1 - 2022

N2 - Water is generally regarded as a universal plasticizer of amorphous drugs or amorphous drug-containing systems. A decrease in glass-transition temperature (T-g) is considered the general result of this plasticizing effect. A recent study exhibits that water can increase the T-g of amorphous prilocaine (PRL) and thus shows an anti-plasticizing effect. The structurally similar drug lidocaine (LID) might show similar interactions with water, and thus an anti-plasticizing effect of water is hypothesized to also occur in amorphous LID. However, the influence of water on the T-g of LID cannot be determined directly due to the very low stability of LID in the amorphous form. It is possible to predict the T-g of LID from a co-amorphous system of PRL-LID using the Gordon-Taylor equation. Interactions were observed between PRL and LID based on the deviations between the experimental T(g)s and the T(g)s calculated by the conventional use of the Gordon-Taylor equation. A modified use of the Gordon-Taylor equation was applied using the optimal co-amorphous system as a separate component and the excess drug as the other component. The predicted T-g of fully hydrated LID could thus be determined and was found to be increased by 0.9 +/- 0.7 K compared with the T-g of water-free amorphous LID. It could be shown that water exhibited a small anti-plasticizing effect on LID.

AB - Water is generally regarded as a universal plasticizer of amorphous drugs or amorphous drug-containing systems. A decrease in glass-transition temperature (T-g) is considered the general result of this plasticizing effect. A recent study exhibits that water can increase the T-g of amorphous prilocaine (PRL) and thus shows an anti-plasticizing effect. The structurally similar drug lidocaine (LID) might show similar interactions with water, and thus an anti-plasticizing effect of water is hypothesized to also occur in amorphous LID. However, the influence of water on the T-g of LID cannot be determined directly due to the very low stability of LID in the amorphous form. It is possible to predict the T-g of LID from a co-amorphous system of PRL-LID using the Gordon-Taylor equation. Interactions were observed between PRL and LID based on the deviations between the experimental T(g)s and the T(g)s calculated by the conventional use of the Gordon-Taylor equation. A modified use of the Gordon-Taylor equation was applied using the optimal co-amorphous system as a separate component and the excess drug as the other component. The predicted T-g of fully hydrated LID could thus be determined and was found to be increased by 0.9 +/- 0.7 K compared with the T-g of water-free amorphous LID. It could be shown that water exhibited a small anti-plasticizing effect on LID.

KW - co-amorphous

KW - glass transition

KW - molecular interaction

KW - anti-plasticizing effect

KW - lidocaine

U2 - 10.1021/acs.molpharmaceut.2c00339

DO - 10.1021/acs.molpharmaceut.2c00339

M3 - Journal article

C2 - 35876141

VL - 19

SP - 3199

EP - 3205

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 9

ER -

ID: 318528304